About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
An Unusual Cause of Multiple Left Ventricle Thrombi in a Young Woman
Sofien Zayed1, Rami Tlili1, Fares Azaiez1, Rim Hentati1, Fatma Zouari1, Rim Ben Romdhane1, Rania Hammami2, Youssef Ben Ameur1
1Department of Cardiology, Mongi Slim University Hospital La Marsa, Tunis, Tunisia; 2Department of Cardiology, HediChaker University Hospital, Sfax, Tunisia.
Corresponding Author:
Dr. Zayed Sofien
Email: sofienzayed91@gmail.com 
Received: 07-JAN-2020 Accepted: 28-JUL-2020 Published Online: 15-SEP-2020
DOI: http://dx.doi.org/10.17659/01.2020.0050
Abstract
Background: Antiphospholipid syndrome (APS) is a rare autoimmune disease with an increased risk of vascular occlusion and pregnancy complications. As a multisystemic disease, the heart is usually affected by direct (autoimmune action) or indirect (thrombosis) pathological mechanisms. Case Report: A 40-year-old diabetic and hypertensive woman presented with congestive heart failure. The echocardiographic exploration showed reduced left ventricle ejection fraction (20%) and diffuse wall motion abnormalities with multiple large thrombi in the left ventricle. The coronary angiography was normal. The APS was confirmed by positive laboratory tests (La, aCL and aß2GPI). Conclusion: The revelation of APS by cardiac manifestations, mainly cardiac thrombosis, is rarely reported in the literature, and evolution is usually unfavorable.
Keywords : Coronary Angiography, Echocardiography, Heart Diseases, Lupus Coagulation Inhibitor, Thrombosis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025